Search Results

Synthesis and Biological Study of 3-Butyl-1-(2,6-dichlorophenyl)-1H-[1,2,4]triazol- 5(4H)-one Derivatives as Anti-hypertension Drugs

Authors: Zhang, Yanchun; Zhou, Jinpei; Pan, Weihong; Wu, Xiaoming; Wang, Shuai

Source: Letters in Drug Design & Discovery, Volume 7, Number 1, January 2010 , pp. 18-22(5)

Publisher: Bentham Science Publishers

Modulation of the renin-angiotensin-aldosterone system in sepsis: a new therapeutic approach?

Authors: Salgado, Diamantino Ribeiro; Rocco, José Rodolfo; Silva, Eliézer; Vincent, Jean-Louis

Source: Expert Opinion on Therapeutic Targets, Volume 14, Number 1, January 2010 , pp. 11-20(10)

Publisher: Informa Healthcare

Effects of raloxifene on the renin-angiotensin-aldosterone system and blood pressure in hypertensive and normotensive osteoporotic postmenopausal women

Authors: Sumino, Hiroyuki; Ichikawa, Shuichi; Kasama, Shu; Takahashi, Takashi; Kumakura, Hisao; Takayama, Yoshiaki; Kanda, Tsugiyasu; Murakami, Masami; Kurabayashi, Masahiko

Source: Geriatrics and Gerontology International, Volume 10, Number 1, January 2010 , pp. 70-77(8)

Publisher: Blackwell Publishing

Angiotensin II antagonists in patients with recurrent hepatitis C virus infection after liver transplantation

Authors: Cholongitas, Evangelos; Vibhakorn, Shusang; Lodato, Francesca; Burroughs, Andrew K.

Source: Liver International, Volume 30, Number 2, February 2010 , pp. 334-335(2)

Publisher: Blackwell Publishing

New Strategies and Drugs in the Treatment of Hypertension: Monotherapy or Combination?

Authors: Destro, Maurizio; Cagnoni, Francesca; D'Ospina, Antonio; Ricci, Alessandra R.; Zaninelli, Augusto; Preti, Paola

Source: Recent Patents on Cardiovascular Drug Discovery, Volume 5, Number 1, January 2010 , pp. 69-81(13)

Publisher: Bentham Science Publishers

Treatment Strategies to Minimize or Prevent Chronic Allograft Dysfunction in Pediatric Renal Transplant Recipients: An Overview

Authors: Höcker, Britta; Tönshoff, Burkhard

Source: Pediatric Drugs, Volume 11, Number 6, 1 December 2009 , pp. 381-396(16)

Publisher: Adis International

Effect on the Atherogenic Marker Plasminogen Activator Inhibitor Type-1 of Addition of the ACE Inhibitor Imidapril to Angiotensin II Type 1 Receptor Antagonist Therapy in Hypertensive Patients with Abnormal Glucose Metabolism: A Prospective Cohort Study in Primary Care

Authors: Yajima, Ken; Shimada, Akira; Hirose, Hiroshi; Oikawa, Yoichi; Yamada, Satoru; Meguro, Shu; Irie, Junichiro; Irie, Seiko

Source: Clinical Drug Investigation, Volume 29, Number 12, 1 December 2009 , pp. 811-819(9)

Publisher: Adis International

Antagonist of the Type-1 ANG II receptor prevents against LPS-induced septic shock in rats

Authors: Hagiwara, Satoshi; Iwasaka, Hideo; Hidaka, Seigo; Hasegawa, Akira; Koga, Hironori; Noguchi, Takayuki

Source: Intensive Care Medicine, Volume 35, Number 8, August 2009 , pp. 1471-1478(8)

Publisher: Springer

Irbesartan-mediated reduction of renal and cardiac damage in insulin resistant JCR : LA-cp rats

Authors: Russell, JC; Kelly, SE; Vine, DF; Proctor, SD

Source: British Journal of Pharmacology, Volume 158, Number 6, November 2009 , pp. 1588-1596(9)

Publisher: Blackwell Publishing

Adherence to Antihypertensive Medications: A Review and Update

Authors: >Francesco Vittorio Costa,; D'Ausilio, Anna; Bianchi, Cosetta; Negrini, Cristina; Lopatriello, Stefania

Source: High Blood Pressure & Cardiovascular Prevention, Volume 16, Number 3, 1 September 2009 , pp. 101-110(10)

Publisher: Adis International

Effects of AT1- and β-adrenergic receptor antagonists on TGF-β1-induced fibrosis in transgenic mice

Authors: Seeland, U.; Schäffer, A.; Selejan, S.; Hohl, M.; Reil, J.-C.; Müller, P.; Rosenkranz, S.; Böhm, M.

Source: European Journal of Clinical Investigation, Volume 39, Number 10, October 2009 , pp. 851-859(9)

Publisher: Blackwell Publishing

Fixed-Dose Combinations as Initial Therapy for Hypertension: A Review of Approved Agents and a Guide to Patient Selection

Authors: Waeber, Bernard; Feihl, François; Ruilope, Luis M.

Source: Drugs, Volume 69, Number 13, 10 September 2009 , pp. 1761-1776(16)

Publisher: Adis International

Role of Angiotensin II Type 1 Receptor Antagonists in the Treatment of Hypertension in Patients Aged ≥65 Years

Author: Gradman, Alan H.

Source: Drugs & Aging, Volume 26, Number 9, 1 September 2009 , pp. 751-767(17)

Publisher: Adis International

Angiotensin II-generating enzymes, angiotensin-converting enzyme (ACE) and mast cell chymase (CMA1), in gastric inflammation may be regulated by H. pylori and associated cytokines

Authors: Carl-McGrath, Stacy; Grantzdorffer, Ilona; Lendeckel, Uwe; Ebert, Matthias; Rocken, Christoph

Source: Pathology, Volume 41, Number 5, August 2009 , pp. 419-427(9)

Publisher: Informa Healthcare

One-Year Renal and Cardiac Effects of Bisoprolol versus Losartan in Recently Diagnosed Hypertensive Patients: A Randomized, Double-Blind Study

Authors: Parrinello, Gaspare; Paterna, Salvatore; Torres, Daniele; >Pietro Di Pasquale,; Mezzero, Manuela; >Gabriella La Rocca,; Cardillo, Mauro; Trapanese, Caterina; Caradonna, Mario; Licata, Giuseppe

Source: Clinical Drug Investigation, Volume 29, Number 9, 1 September 2009 , pp. 591-600(10)

Publisher: Adis International

Idiopathic Membranous Nephropathy: Management Strategies

Authors: Quaglia, Marco; Stratta, Piero

Source: Drugs, Volume 69, Number 10, 9 July 2009 , pp. 1303-1317(15)

Publisher: Adis International

Angiotensin II enhances the afferent arteriolar response to adenosine through increases in cytosolic calcium

Authors: Lai, E. Y.; Patzak, A.; Persson, A. E. G.; Carlström, M.

Source: Acta Physiologica, Volume 196, Number 4, August 2009 , pp. 435-445(11)

Publisher: Blackwell Publishing

Investigational vasopressin receptor modulators in the pipeline

Authors: Favory, Raphaël; Salgado, Diamantino R; Vincent, Jean-Louis

Source: Expert Opinion on Investigational Drugs, Volume 18, Number 8, August 2009 , pp. 1119-1131(13)

Publisher: Informa Healthcare

The Myth of Janus: The Two Faces of Renal Outcomes in the ONTARGET Study

Author: Volpe, Massimo

Source: High Blood Pressure & Cardiovascular Prevention, Volume 16, Number 2, 2 June 2009 , pp. 35-37(3)

Publisher: Adis International

Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?

Authors: Burnier, Michel; Pruijm, Menno; Wuerzner, Gregoire

Source: Expert Opinion on Drug Metabolism and Toxicology, Volume 5, Number 8, August 2009 , pp. 981-987(7)

Publisher: Informa Healthcare